Key Events This Week
Aug 3: Bullish technical momentum observed despite mixed returns
Aug 3: Valuation shifts from very expensive to expensive prompt caution
Aug 7: Week closes at Rs.86.06, down 1.03%
Aug 07, 03:30 PM
BSE+NSE Vol: 9.58 lacs
Aug 3: Bullish technical momentum observed despite mixed returns
Aug 3: Valuation shifts from very expensive to expensive prompt caution
Aug 7: Week closes at Rs.86.06, down 1.03%

Niva Bupa Health Insurance Company Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 03 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Niva Bupa Health Insurance Company Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a modest day gain of 1.18%, the stock’s technical indicators reveal a complex interplay of signals that investors should carefully analyse before making decisions.
Read full news article
Niva Bupa Health Insurance Company Ltd has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions amid a complex backdrop of sector dynamics and peer comparisons, prompting investors to reassess the stock’s price attractiveness in the insurance space.
Read full news article
27 Jul: Stock opens at Rs.86.90 with positive start
30 Jul: Technical momentum shifts amid mixed market signals
31 Jul: Mixed quarterly results reported with Mojo Grade downgraded
31 Jul: Exceptional volume surge despite modest price change
Niva Bupa Health Insurance Company Ltd's latest financial results for Q1 FY27 reflect a notable performance in terms of revenue growth and operational efficiency. The company reported net sales of ₹2,273.72 crores, which represents a year-on-year growth of 28.56% from ₹1,768.61 crores in the previous year. This growth is complemented by a sequential increase of 7.44% from the previous quarter, indicating sustained business expansion despite typical seasonal challenges. The net profit for the quarter stood at ₹137.80 crores, marking a significant year-on-year increase of 92.93%. However, it is important to note that this figure reflects a decline of 13.54% compared to the previous quarter's profit. The operating profit margin, excluding other income, improved to 8.10%, up from 5.55% in Q1 FY26, although it showed a slight decrease from the previous quarter's margin of 8.58%. This margin expansion suggests e...
Read full news article
Niva Bupa Health Insurance Company Ltd witnessed one of the highest trading volumes in the market on 31 Jul 2026, with over 7.64 million shares changing hands. Despite this surge in activity, the stock closed lower by 1.21% at ₹86.22, reflecting a complex interplay of investor sentiment amid sector gains and shifting ratings.
Read full news article
Niva Bupa Health Insurance Company Ltd. delivered a robust first quarter for FY2027, posting net profit of ₹137.80 crores, representing a remarkable 92.93% year-on-year surge from ₹71.44 crores in Q1 FY26. However, the sequential performance revealed a different narrative, with profits declining 13.54% from the preceding quarter's ₹159.36 crores. The stock closed at ₹85.83 on July 31, down 0.14% on the day, trading near its 52-week high of ₹91.39 but carrying a premium valuation that raises questions about sustainability at a market capitalisation of ₹15,871.97 crores.
Read full news article
Niva Bupa Health Insurance Company Ltd has reported a robust quarterly performance for June 2026, marked by record net sales and significant profit growth, although its nine-month profitability trend remains subdued. The company’s financial trend rating has shifted from very positive to positive, reflecting a nuanced outlook amid strong quarterly gains and some longer-term challenges.
Read full news articleCopies of newspaper publication
Transcript of earning call
Outcome of Board meeting held on July 30 2026- Unaudited financial results for quarter ended June 2026 and raising of funds by way of issuance of Debentures
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available